Verlekar D - Search Results

1

MYC transcription activation mediated by OCT4 as a mechanism of resistance to 13-cisRA-mediated differentiation in neuroblastoma.

Wei SJ, Nguyen TH, Yang IH, Mook DG, Makena MR, Verlekar D, Hindle A, Martinez GM, Yang S, Shimada H, Reynolds CP, Kang MH. Wei SJ, et al. Among authors: verlekar d. Cell Death Dis. 2020 May 14;11(5):368. doi: 10.1038/s41419-020-2563-4. Cell Death Dis. 2020. PMID: 32409685 Free PMC article.

2

Cytotoxic activity of difluoromethylornithine compared with fenretinide in neuroblastoma cell lines.

Makena MR, Cho HE, Nguyen TH, Koneru B, Verlekar DU, Hindle A, Kang MH, Reynolds CP. Makena MR, et al. Among authors: verlekar du. Pediatr Blood Cancer. 2018 Dec;65(12):e27447. doi: 10.1002/pbc.27447. Epub 2018 Sep 24. Pediatr Blood Cancer. 2018. PMID: 30251395 Free PMC article.

3

Ceramide synthase-6 confers resistance to chemotherapy by binding to CD95/Fas in T-cell acute lymphoblastic leukemia.

Verlekar D, Wei SJ, Cho H, Yang S, Kang MH. Verlekar D, et al. Cell Death Dis. 2018 Sep 11;9(9):925. doi: 10.1038/s41419-018-0964-4. Cell Death Dis. 2018. PMID: 30206207 Free PMC article.

4

Cytotoxicity and molecular activity of fenretinide and metabolites in T-cell lymphoid malignancy, neuroblastoma, and ovarian cancer cell lines in physiological hypoxia.

Song MM, Makena MR, Hindle A, Koneru B, Nguyen TH, Verlekar DU, Cho H, Maurer BJ, Kang MH, Reynolds CP. Song MM, et al. Among authors: verlekar du. Anticancer Drugs. 2019 Feb;30(2):117-127. doi: 10.1097/CAD.0000000000000696. Anticancer Drugs. 2019. PMID: 30272587

5

Vorinostat and fenretinide synergize in preclinical models of T-cell lymphoid malignancies.

Makena MR, Nguyen TH, Koneru B, Hindle A, Chen WH, Verlekar DU, Kang MH, Reynolds CP. Makena MR, et al. Among authors: verlekar du. Anticancer Drugs. 2021 Jan 1;32(1):34-43. doi: 10.1097/CAD.0000000000001008. Anticancer Drugs. 2021. PMID: 33079733

6

Metabolic characteristics of 13-cis-retinoic acid (isotretinoin) and anti-tumour activity of the 13-cis-retinoic acid metabolite 4-oxo-13-cis-retinoic acid in neuroblastoma.

Sonawane P, Cho HE, Tagde A, Verlekar D, Yu AL, Reynolds CP, Kang MH. Sonawane P, et al. Among authors: verlekar d. Br J Pharmacol. 2014 Dec;171(23):5330-44. doi: 10.1111/bph.12846. Br J Pharmacol. 2014. PMID: 25039756 Free PMC article. Clinical Trial.

7

Wnt/β-Catenin Signaling: The Culprit in Pancreatic Carcinogenesis and Therapeutic Resistance.

Ram Makena M, Gatla H, Verlekar D, Sukhavasi S, K Pandey M, C Pramanik K. Ram Makena M, et al. Among authors: verlekar d. Int J Mol Sci. 2019 Aug 30;20(17):4242. doi: 10.3390/ijms20174242. Int J Mol Sci. 2019. PMID: 31480221 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters